Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, CFG

/R E P E A T -- Notice to the Media - COVID-19 Update (September 25, 2020) - The Prime Minister, Ministers and Government of Canada officials to hold a news conference on coronavirus disease/


OTTAWA, ON, Sept. 25, 2020 /CNW/ - The Prime Minister, Ministers and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19).

Date
September 25, 2020

Time
12:00 PM (EDT)

Location
West Block, Room 225
Parliament Hill
Wellington Street, Ottawa, Ontario

The media availability will also be held by teleconference.
Toll-free (Canada/US) dial-in number:
1-866-206-0153
Local dial-in number: 613-954-9003

Passcode: 1622050#

Twitter: @GovCanHealth
Facebook: Healthy Canadians

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 08:55
The "Indonesia Construction Equipment Rental Market - Strategic Assessment & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Indonesia construction equipment rental market was valued at $474.1 in 2023 and is...

at 08:45
MastercardBy Vicki HymanPhilanthropist Melinda French Gates, right, spoke with Rosario Dawson, an actor and activist for gender equality, left, and Fatoumata Bâ, center, the founder and executive chair of Janngo Capital, about how to close the...

at 08:45
The Quest Diagnostics Foundation today announced an expanded collaboration with Green Bronx Machine (GBM), a transformational educational nonprofit...

at 08:35
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor...

at 08:25
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...



News published on and distributed by: